+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Thrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Pre Book Price: $ 5216

Original Price: $ 5795

Hemostasis is a medical condition, wherein blood vessel, platelets, and coagulation factors act together to arrest bleeding. It occurs by coagulation process, wherein blood is transformed from liquid to gel state through sequential enzymatic steps. During hemostasis process, thrombin plays a role of key enzyme. Thrombin is an enzyme called serine protease, which is synthesized from a precursor glycoprotein called prothrombin. During the clotting process, proteolytic cleavage of prothrombin produces thrombin. Insoluble fibrin is produced from soluble fibrinogen through a series of reactions catalyzed by thrombin. The production of thrombin in body is highly regulated, as the overproduction of thrombin may result in the blockage of normal blood flow– a state called thrombosis. Under such condition, tissues may die due to unavailability of oxygen.

Prothrombin is produced in liver and is passed into blood stream in an inactive form. Whenever a vascular injury occurs, collagen and tissue factor lead to activation of coagulation pathways. These pathways lead to activation of factor X, which, in conjugation with other factors, forms a complex. This complex cleaves the prothrombin protein into a thrombin molecule. Once thrombin is produced, it cleaves fibrinogen into fibrin. This result in platelet aggregation and thrombus formation, which help in the stoppage of bleeding.

Thrombin acts on different cell types. On smooth muscle cells, it causes vasoconstriction. It activates platelets to promote their aggregation at the site of injury. In activated state, thrombin plays a role of chemo-attractant and mitogen for neutrophils and fibroblasts. Thrombin also plays a role in regulating the endothelial cell functions. It also plays a role in the anticoagulant system, wherein it activates protein C upon interaction with thrombomodulin. This helps in improving circulation as an anticoagulant effect during the vascular injury. Thrombin are produced naturally in body and is also available in commercialized forms. In both the forms, it has two important functions. It helps in the process of coagulation wherein fibrinogen is converted into fibrin. This promotes platelet aggregation, which helps in clotting of blood at the site of injury. Secondly, it acts in the anticoagulation process by activating the protein C. Commercially produced thrombin is available in concentrated form, which, upon application, is capable of converting fibrinogen into fibrin. This helps in thrombus formation at the site of injury. The concentration of thrombin is directly promotional to the rate of clot formation. Types of commercially available thrombin differ in terms of dosage form and concentration. This factor is considered while selecting the product, as higher concentration speeds up the process of hemostasis.

The global thrombin market can be segmented on the basis of product type, dosage form, end-user, and geographical region. Based on product type, the market has been segmented into bovine thrombin, human thrombin, and recombinant thrombin. The human thrombin segment is sub-segmented into alpha, beta, and gamma thrombin. The use of bovine thrombin generates antibodies, which cross-react with human coagulation proteins. This has been observed to result in severe complications and life-threatening bleeding. Hence, human thrombin was introduced, as an alternative to bovine thrombin. However, human thrombin is associated with the risk of transmission of viruses. The recombinant thrombin segment is anticipated to lead the market, as recombinant thrombin is free of risks associated with viral infection and it has potential efficacy.

Based on dosage form, the global thrombin market has been segmented into powder form, solution form, pad form, spray kits, and others. Based on end-user, it can be segmented into hospitals, diagnostics & clinics, and academic and research institutes. The hospitals segment is anticipated to lead the market, due to increase in the number of surgeries.

Based on geography, the global thrombin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to lead the global market, due to increase in the number of surgeries and developed health care infrastructure.

Key players operating in the global thrombin market are Baxter, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer, Octapharma, Omrix Biopharmaceuticals Ltd., and Shanghai RAAS. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. 

 


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top